The 3rd National Eye and Tissue Banking Conference will be held on the 3-4 March 2026 at Meers Hall, Art Gallery of NSW.
The two‑day program will feature keynote presentations, research papers and panel
more
Event Details
The 3rd National Eye and Tissue Banking Conference will be held on the3-4 March 2026atMeers Hall, Art Gallery of NSW.
The two‑day program will feature keynote presentations, research papers and panel discussions, providing plenty of opportunities to learn, exchange ideas and connect with colleagues across the Tissue and Eye Banking community.
This year’s social event will take place at Porcellino on the evening of March 3rd, set within the picturesque forecourt of one of Australia’s oldest and most historic medical institutions, the Sydney Eye Hospital, which also houses the NSW Tissue Bank. It’s just a short walk from the conference venue at the Art Gallery of NSW.
Call for abstracts – We are no longer accepting abstracts.
Registration – You can register for the Eye & Tissue Banking conference at the ANZ Corneal Society conference shared website. Start your registration: Registration Link
Registration deadline is February 22nd 2026.
Please note that a $350 ticket for the eye and tissue conference includes the social event. An additional social event ticket is only required for a plus one.
We are delighted to welcome our keynote speakers listed below. More speakers and invited guests will be added as confirmed.
Professor Wei Chen
Vice Chair, Eye Hospital, Wenzhou Medical University
Professor Wei Chen is Vice-Chair and Professor of Ophthalmology in the affiliated eye hospital of Wenzhou Medical University and Director of Eye Clinic in Boao Super Hospital in China. He graduated from Wenzhou Medical University with Medical Degree in 1998 and Shanghai Fudan university with PhD in 2002.
He was trained as postdoctoral research fellow in Schepens Eye Research Institute in Harvard Medical School and Ocular Surface Center in Baylor College of Medicine. He was an author on over internationally 100 peer-reviewed publications such as Nature Communication, NPJ Digital Medicine, Genome Medicine, Ophthalmology, The Ocular Surface, AJO, IOVS, BJO, Cornea etc. He has attracted over US$5,000,000 in grants and awards. He has more than 30 patents at home and abroad. He also served as reviewer for more than 10 international journals including Nature Communication, Ocular Surface, IOVS, BJO, Cornea, Cell reports medicine, etc. He is Editorial Board member of APJO, chairman of TFOS China, founding member of Asia Dry Eye Society. He had been invited as speaker in 30 international conferences. He has more than 3000 cases of experiences of DALK, DSAEK/DMEK, PKPs and Boston Keratoprothesis surgeries. His clinical and research interests include molecular mechanism of dry eye, corneal engineering, translational research, corneal transplantation. He established a Boston Keratoprothesis surgery center in Eye Clinic of Boao Super Hospital, the only hospital in China which can legally use any FDA or CE approved devices and medicine to treat patients without approval of China FDA.
Professor Hong Zhang
Dean of the School of Ophthalmology and Optometry at Harbin Medical University
Professor, doctoral supervisor. Longjiang Scholar Distinguished Professor, Longjiang Craftsman, First Longjiang Famous Doctor, Outstanding Youth of Heilongjiang Province, Leading Talent of Heilongjiang Province Universities, Star Alliance Professor of Harbin Medical University, and People’s Good Doctor. Principal Investigator of University of Melbourne (2010-2015), and honorary professor of Bashkir State Medical University.
Currently serving as the Dean of the School of Ophthalmology and Optometry at Harbin Medical University, the Vice President of the First Affiliated Hospital of Harbin Medical University. More than 20 academic part-time positions, including Vice Chairman of the Youth Committee of the Ophthalmology Branch of the Chinese Medical Association and Member of the Corneal Disease Professional Committee of the Ophthalmology Society of the Chinese Medical Association.
As director of the Eye Bank of Heilongjiang Province, performed tens of thousands of PKDALKDSEAKDMEK and other complicated surgeries. My research interest focused on cornea diseased like corneal infection, dry eye, corneal transplantation and tissue engineering, and drug delivery system. Gained over 40 scientific research projects (including Chinese and Australian national key projects such as the Grant of National Natural Science Foundation, NHMRC and NHMRC Development grants) and published over 100 domestic and international papers, 15 textbooks . Participate in over 20 clinical guidelines and penner of Consensus on the Diagnosis and Treatment of Dry Eye Associated with Systemic Immune Diseases.
Richard Lomas
Head of Development for the UK’s NHS Blood and Transplant
A scientist with >30 years experience in tissue banking, primarily in research, development and validation. My current role is Head of Development for NHSBT Tissue and Eye Services. NHSBT is a public sector organization that co-ordinates organ donation across the UK, blood donation in England, and the majority of tissue donation, banking and supply across the UK.
I am a state registered Clinical Scientist with the UK Health Care Professions Council (Registration No. CS18590)
I am closely involved with the development of European regulation and guidance for tissue banking as part of the writing group for the European Department for the Quality of Medicines (EDQM) Tissue and Cell Guide, and the development of risk assessment tools (EuroGTP2 and MiRCA) that are integral for the development of tissue banking protocols.
I teach on post-graduate Transfusion and Transplantation courses provided by the Universities of Bristol and Manchester, and on Quality Management courses delivered by the EDQM, and have previously participated in training programs run by the European Union to assist member countries to develop tissue banking systems.
From 2017-2025 I served as General Secretary of the European Association of Tissue and Cell Banks
Martin Börgel
Managing Director of the German Society of Tissue Transplantation
Experienced health economist with over 20+ years of experience in managing and consulting entities in SoHo Sector in Germany, Europe and International. Demonstrated expertise and management skills in consulting Hospitals and several other entities in the healthcare sector. Experienced in Process reorganization and optimization, trained as Certified DIN ISO Auditor. Project Manager for establishing the German OPO and Eurotransplant as responsible Entities for the German Organ Donation system. Since 2002 CEO of the German Association of Tissue Transplantation (DGFG gGmbH), Network of 14 Tissue Banks in Germany, responsible for 50+% of all German tissue donations. Ceo of Tissue Bank HELIOS Schwerin. Member of Management Board Tissue Bank Treviso (FBTV). President EATCB, general Secretary of WUTBA. Member of DTI Faculty. Highly skilled in systematic structure and process analysis of entities and donation systems, development of organizations and multifunctional groups in national and international health care system in the field of SoHo. Ensuring target and result driven management tools to achieve optimum results for non-profit entities. Today, DGFG is jointly supported by four university hospitals and one protestant hospital, employs more than 120 staff members, and operates a total of 14 tissue banks. The DGFG is a non-profit network.
Dr. Joanneke Maitz
Burns Surgeon-Scientist
Specialist surgeon in burns, plastic, and reconstruction, and an accomplished researcher in translational burn injury and skin tissue engineering. She leads the Burns & Reconstructive Surgery Research Group at Concord Hospital and is a Senior Clinical Lecturer at the University of Sydney.
Dr Maitz’s research focuses on advancing bioengineered solutions for burns treatment and reconstructive surgery, with emphasis on next-generation skin substitutes and improving outcomes for patients with severe soft-tissue loss. In 2025, the Concord Hospital Burns Unit received the NSW Health Innovation Award in recognition of this landmark research program. The Unit’s pioneering 3D-bioprinted skin project, now in a first-in-human clinical trial, represents a major step forward in personalised regenerative medicine. Initially developed for burns victims, this technology has the potential to transform treatment for a wide range of soft tissue defects, offering new hope for patients who previously had limited reconstructive options.
Jonathan Boyd
Jonathan brings more than 16 years of dedicated experience in tissue banking, spanning frontline recovery roles through to senior operational leadership. His career reflects a deep commitment to the ethical, safe, and effective provision of human tissues for transplantation, and a comprehensive understanding of the full donation and processing pathway.
Jonathan has developed extensive expertise across donor assessment, tissue recovery, quality systems, regulatory compliance, and team leadership. His work is grounded in technical precision and a strong focus on best-practice standards, ensuring that donated tissues are handled with the utmost care and integrity. Jonathan earned his undergraduate degree in communications and his Masters of Science degree in management. He is a Certified Tissue Bank Specialist and a certified Lean Six Sigma Black Belt. His well-rounded expertise positions him as a trusted leader and a committed advocate for advancing tissue banking to directly improve patient outcomes.
Top 10 Hotels Near the Art Gallery of NSW & Sydney Eye Hospital
Hotel Summaries
Pullman Quay Grand Sydney Harbour
Distance to Art Gallery: 10-12 min
Distance to Eye Hospital: 12-15 min
Category: 5* | Pricing: Luxury ($350+)
Airport Access: Train to Circular Quay -> 6 min walk; Taxi ~20-25 min
Sheraton Grand Sydney Hyde Park
Distance to Art Gallery: 12-15 min
Distance to Eye Hospital: 15 min
Category: 5* | Pricing: Luxury ($350+)
Airport Access: Train to St James -> 4 min walk; Taxi ~20 min
InterContinental Sydney
Distance to Art Gallery: 10-12 min
Distance to Eye Hospital: 12-14 min
Category: 5* | Pricing: Luxury ($350+)
Airport Access: Train to Circular Quay -> 5 min walk
Sofitel Sydney Wentworth
Distance to Art Gallery: 10-12 min
Distance to Eye Hospital: 12-14 min
Category: 5* | Pricing: Luxury ($350+)
Airport Access: Train to Martin Place -> 5 min walk
It is our great pleasure to invite you to the 41st Australian and New Zealand Cornea Society (ANZCS) meeting, to be held 5-6 March 2026 in Sydney. This year’s
more
Event Details
It is our great pleasure to invite you to the 41st Australian and New Zealand Cornea Society (ANZCS) meeting, to be held 5-6 March 2026 in Sydney. This year’s theme, The Art of Cornea, reflects our vision for a conference that not only advances clinical knowledge but also celebrates creativity, collaboration, and the beauty of discovery in ophthalmology.
We are delighted to welcome eye bank professionals, scientists, optometrists, fellows, registrars, ophthalmologists, and all with a passion for corneal diseases to come together in this open clinical forum. The ANZCS meeting is an opportunity to enhance expertise and explore the latest innovations in an open and friendly forum, while reconnecting with colleagues and friends in person.
Our 41st meeting will take place at the Swissôtel Sydney, ideally located in the heart of the city, with easy access to Sydney’s cultural highlights.
Gala Dinner
This year’s gala dinner promises to be truly special as it will take place in the recently renovated Art Gallery of New South Wales. Imagine networking and celebrating among art, light, and ambiance; a perfect blend of culture and collegiality. We hope you’ll join us for what will be a memorable evening.
Guest Speakers
We are honoured to introduce Dr Alain Saad, who will deliver the keynote address. Those with a special interest in complex corneal surgery (including DMEK/DSAEK techniques) and the evolving role of artificial intelligence in biometry and keratoconus screening will already be familiar with his name.
Dr Saad is co-author of the SCORE (Screening Corneal Objective Risk of Ectasia) Analyzer, an algorithm for early detection of subclinical keratoconus and post-LASIK ectasia risk. He is also a contributor to the open-source, machine-learning-based PEARL-DGS Formula (Prediction Enhanced by Artificial intelligence & Linear output/Debellemanière-Gatinel-Saad) for intraocular lens power calculation.
His research spans anterior segment and refractive surgery, corneal transplantation, biometry, and ectasia risk assessment, making him ideally placed to discuss the convergence of advanced surgery and AI-driven diagnostics.
Though early in his career, Dr Saad’s impact has been substantial through diagnostic innovation, scholarly publication, and translation of research into clinical tools. His keynote will offer valuable insight into the future of corneal surgery, screening, and diagnostic innovation.
Mr Adam Spencer, an icon of Australian media will give the John Blandford Lecture. Adam is a leading voice in artificial Intelligence, cybersecurity and the Chat GPT revolution. He’s all about growing knowledge and getting conversations started for some of the world’s biggest brands and iconic Aussie institutions.
For further information including registration and accommodation bookings, please see the meeting flyer.
Register by 31 December 2025 to take advantage of the Early Bird rate.
We look forward to your involvement and to welcoming you to what promises to be a scientifically rich and socially engaging event.
Welcome to the XXXVII Meeting of the European Eye Bank Association (EEBA 2026), organised in collaboration with the Asociación Española de Bancos de Tejidos (AEBT) which will take place in A Coruña from 19 to 21 March 2026. The European Union’s new SoHO Regulation, which covers blood, tissues and cells, will enter into force in August 2027. This new scenario aims to improve patient and donor safety, foster innovation, harmonize standards across the EU, and will have an impact on all those entities and establishments that retrieve, test, process, preserve, store and distribute human donor tissue for therapeutic application.
Abstracts
The deadline for submission of abstracts is 24 November 2025.
TheScientific Programme for EEBA 2026is organized into workshops, keynote lectures, free oral presentations and posters, and offers speakers the opportunity to share their most recent scientific developments, experiences and know-how with fellow eye banking professionals, medical experts, researchers and experienced ophthalmologists from Europe and abroad. The Local Organizing Committee encourages you to present your expertise and insight in the field of cornea banking and transplantation and to take advantage of the networking possibilities with international peers and experts in order to advance best practice and facilitate communication between all the different stakeholders involved in corneal transplantation, eye banking and the treatment of ocular surface diseases.
Accepted abstracts will be published as a dedicated supplement in the scientific journalBMJ Open Ophthalmology, and all free oral and poster presentations will have the chance to be considered for Best Oral Paper/Poster Awards.
